The Specific Aims of the Clinical Core are: 1) To recruit, screen and enroll into research protocols subjects from defined populations; to follow patients prospectively on studies, maintaining close adherence to study procedures (Project I, III and IV); 2) To collect prospective data on the epidemiology and natural history of HSV infection in immunocompetent and immunocompromised (HIV-infected) persons; to obtain clinical specimens required for virologic and immunologic laboratory investigations; and, 3) To develop new clinical techniques for conducting virologic, epidemiologic, and immunologic investigations of HSV infections. The Clinical Core will enroll and follow study subjects enrolled in studies proposed in Project I, Project III and Project IV. The Core is located at the Virology Research Clinic (VRC) at the University of Washington. The VRC has followed . 8,000 subjects in 173 clinical studies. A unique strength of the clinic staff is their ability to recruit, enroll and follow patients with genital HSV infection for prolonged periods of time. The process of enrolling patients into study protocols is standardized, as is collection of specimens. The evaluation and clinical care of subjects with newly acquired or recurrent genital herpes follows established procedures. Several specialized procedures have been developed and tested at the VRC. The protocols for daily collection of swabs of genital secretions and the collection of samples for assaying antibodies and HSV specific T cell from mucosal sites. Invasive and non-invasive methods for obtaining samples for immunologic studies have been developed, e.g., lesional biopsies for studies of cellular immunity. In the last 5 years, the investigations have expanded to include HIV-infected persons. For Project IV, new techniques for non-invasive sampling of lymphocytes from the cervix using cytobrush will be tested. For Project III, partner notification of patients with newly acquired genital herpes will be introduced. A computerized sexual history will be piloted to increase disclosure of high risk behavior. Centralized care of study subjects enrolled in proposed HSV Project Grant studies allows for efficient recruitment, standardized collection of data and assurance that excellent clinical care is provided.

Project Start
2000-04-01
Project End
2001-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
10
Fiscal Year
2000
Total Cost
$166,251
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Schiffer, Joshua T; Swan, Dave A; Roychoudhury, Pavitra et al. (2018) A Fixed Spatial Structure of CD8+ T Cells in Tissue during Chronic HSV-2 Infection. J Immunol 201:1522-1535
Traidl, Stephan; Kienlin, Petra; Begemann, Gabriele et al. (2018) Patients with atopic dermatitis and history of eczema herpeticum elicit herpes simplex virus-specific type 2 immune responses. J Allergy Clin Immunol 141:1144-1147.e5
Ramchandani, Meena; Selke, Stacy; Magaret, Amalia et al. (2018) Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition. Sex Transm Infect 94:568-570
Boucoiran, Isabelle; Mayer, Bryan T; Krantz, Elizabeth M et al. (2018) Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants. Pediatr Infect Dis J 37:627-631
Kleinstein, Sarah E; Shea, Patrick R; Allen, Andrew S et al. (2018) Genome-wide association study (GWAS) of human host factors influencing viral severity of herpes simplex virus type 2 (HSV-2). Genes Immun :
Gottlieb, Sami L; Giersing, Birgitte; Boily, Marie-Claude et al. (2017) Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: Key findings from the World Health Organization Consultation on HSV Vaccine Impact Modelling. Vaccine :
Mayer, Bryan T; Krantz, Elizabeth M; Swan, David et al. (2017) Transient Oral Human Cytomegalovirus Infections Indicate Inefficient Viral Spread from Very Few Initially Infected Cells. J Virol 91:
Posavad, C M; Zhao, L; Dong, L et al. (2017) Enrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tract. Mucosal Immunol 10:1259-1269
Johnston, Christine; Magaret, Amalia; Roychoudhury, Pavitra et al. (2017) Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study. PLoS Med 14:e1002475
Matrajt, Laura; Gantt, Soren; Mayer, Bryan T et al. (2017) Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children. Sci Rep 7:13105

Showing the most recent 10 out of 345 publications